Filing Details
- Accession Number:
- 0001127602-17-022005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-21 16:56:13
- Reporting Period:
- 2017-06-19
- Filing Date:
- 2017-06-21
- Accepted Time:
- 2017-06-21 16:56:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1429996 | Helena Foulkes | One Cvs Drive Woonsocket RI 02895- | Evp, President-Cvs Pharmacy | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-06-19 | 14,303 | $34.96 | 59,300 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2017-06-19 | 6,029 | $34.96 | 65,329 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-06-19 | 20,332 | $76.98 | 44,997 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2017-06-19 | 14,303 | $0.00 | 14,303 | $34.96 |
Common Stock | Stock Option | Disposition | 2017-06-19 | 6,029 | $0.00 | 6,029 | $34.96 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
14,304 | 2014-04-01 | 2021-04-01 | No | 4 | M | Direct |
6,029 | 2012-04-01 | 2018-04-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock (Restricted) | 51,191 | Direct | |
Esop Common Stock | 4,071 | Indirect | By ESOP |
Stock Unit | 55,595 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $45.07 | 2013-04-02 | 2019-04-02 | 19,965 | 19,965 | Direct |
Common Stock | Stock Option | $54.53 | 2014-04-01 | 2020-04-01 | 39,340 | 39,340 | Direct |
Common Stock | Stock Option | $74.29 | 2015-04-01 | 2021-04-01 | 52,452 | 52,452 | Direct |
Common Stock | Stock Option | $102.26 | 2016-04-01 | 2022-04-01 | 59,922 | 59,922 | Direct |
Common Stock | Stock Option | $104.82 | 2017-04-01 | 2023-04-01 | 71,696 | 71,696 | Direct |
Common Stock | Stock Option | $78.05 | 2018-04-03 | 2024-04-03 | 150,268 | 150,268 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2019-04-02 | 19,965 | 19,965 | Direct |
2020-04-01 | 39,340 | 39,340 | Direct |
2021-04-01 | 52,452 | 52,452 | Direct |
2022-04-01 | 59,922 | 59,922 | Direct |
2023-04-01 | 71,696 | 71,696 | Direct |
2024-04-03 | 150,268 | 150,268 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $76.58 and $77.39 per share.
- Option became exercisable in three equal annual installments, commencing 4/1/2014.
- Option became exercisable in four equal annual installments, commencing 4/1/2012.
- Option became exercisable in four equal annual installments, commencing 4/2/2013.
- Option became exercisable in four equal annual installments, commencing 4/1/2014.
- Option became exercisable in four equal annual installments, commencing 4/1/2015.
- Option became exercisable in four equal annual installments, commencing 4/1/2016.
- Option became exercisable in four equal annual installments, commencing 4/1/2017.
- Option becomes exercisable in four equal annual installments, commencing 4/3/2018.